Pacific Center for Financial Services’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-75
Closed -$1K – 402
2022
Q2
$1K Hold
75
– – ﹤0.01% 370
2022
Q1
$1K Hold
75
– – ﹤0.01% 358
2021
Q4
$2K Hold
75
– – ﹤0.01% 351
2021
Q3
$3K Hold
75
– – ﹤0.01% 341
2021
Q2
$4K Hold
75
– – ﹤0.01% 305
2021
Q1
$3K Hold
75
– – ﹤0.01% 298
2020
Q4
$5K Buy
+75
New +$3.08K ﹤0.01% 274

Other funds holding EDIT

Pacific Center for Financial Services's EDIT Position: Q3 2022 in Review

Pacific Center for Financial Services sold out of Editas Medicine (EDIT) in Q3 2022, closing a stake of 75 shares — an estimated $1K sold.

Pacific Center for Financial Services first reported a position in EDIT in Q4 2020 and held it in 7 quarters. The position peaked at $5K in Q4 2020. 265 funds tracked by Wall St. Rank hold EDIT as of Q3 2022.

  • Pacific Center for Financial Services reported no remaining Editas Medicine position as of Q3 2022 after selling out during the quarter.
  • Pacific Center for Financial Services sold 75 Editas Medicine shares in Q3 2022, an estimated $1K.
  • Pacific Center for Financial Services first reported a position in Editas Medicine in Q4 2020 and held it in 7 quarters.
  • Pacific Center for Financial Services's Editas Medicine position peaked at $5K in Q4 2020.
  • 265 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2022.

Based on Pacific Center for Financial Services's 13F filing for Q3 2022, filed 14 Nov 2022.